Direct tumor injection trial offers new hope for tough head & neck cancers

NCT ID NCT07219212

Recruiting now Disease control Sponsor: Johnson & Johnson Enterprise Innovation Inc. Source: ClinicalTrials.gov ↗

Summary

This early-stage study is testing whether injecting an experimental drug called JNJ-90301900 directly into tumors is safe and helps shrink cancer when given alongside standard chemotherapy and radiation. It will enroll about 30 people with locally advanced head and neck squamous cell carcinoma. The main goal is to check for side effects, while also measuring how well the tumors respond to the combined treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SQUAMOUS CELL CARCINOMA OF HEAD AND NECK are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Aichi Cancer Center
RECRUITING

Nagoya, 464-8681, Japan
Centre Henri Becquerel
RECRUITING

Rouen, 76038, France
City of Hope
RECRUITING

Duarte, California, 91010, United States
Emory University
RECRUITING

Atlanta, Georgia, 30308, United States
Gustave Roussy
RECRUITING

Villejuif, 94805, France
Hopital De La Cavale Blanche
RECRUITING

Brest, 29200, France
Hopital La Timone
RECRUITING

Marseille, 13385, France
Mayo Clinic
RECRUITING

Jacksonville, Florida, 32224, United States
Moffit Cancer center
RECRUITING

Tampa, Florida, 33612, United States
Montefiore Medical Center
RECRUITING

The Bronx, New York, 10467, United States
Tokyo Medical University Hospital
RECRUITING

Tokyo, 160-0023, Japan

Conditions

Explore the condition pages connected to this study.

SQUAMOUS CELL CARCINOMA OF HEAD AND NECK